|
Match
|
Document |
Document Title |
|
|
US20130072560 |
RETINAL DERIVATIVES AND METHODS FOR THE USE THEREOF FOR THE TREATMENT OF VISUAL DISORDERS
Compositions of and methods for using synthetic retinal derivatives as retinoid replacements and opsin agonists are provided. |
|
|
US20130072559 |
RETINAL DERIVATIVES AND METHODS FOR THE USE THEREOF FOR THE TREATMENT OF VISUAL DISORDERS
Compositions of and methods for using synthetic retinal derivatives as retinoid replacements and opsin agonists are provided. |
|
|
US20110288170 |
RETINAL DERIVATIVES AND METHODS FOR THE USE THEREOF FOR THE TREATMENT OF VISUAL DISORDERS
Compositions of and methods for using synthetic retinal derivatives as retinoid replacements and opsin agonists are provided. |
|
|
US20110286937 |
SYNTHETIC GLYCOLIPID-CONTAINING LIPOSOME
The present invention provides a glycolipid-containing liposome. In such a glycolipid-containing liposome, the glycolipid includes a plant ceramide portion and a sugar chain portion. The present... |
|
|
US20110183943 |
CONCURRENT THERAPY REGIME/REGIMEN FOR THE TREATMENT OF ACNE RELATED DISEASES
A novel therapy regime/regimen for the treatment of acne related diseases includes administering a topical fixed-dose combination of a retinoid and an anti-bacterial agent, such as BPO, to a... |
|
|
US20140179723 |
LOCAL COCHLEAR APPLICATION OF STATINS FOR STIMULATING NEURITE REGROWTH IN THE COCHLEA
Statin compositions are disclosed for stimulating neurite growth from spiral ganglion neurons in the inner ear and methods for preventing damage to or treating damage of auditory neurons and/or... |
|
|
US20140221484 |
GENETIC POLYMORPHISMS ASSOCIATED WITH CARDIOVASCULAR DISORDERS AND DRUG RESPONSE, METHODS OF DETECTION AND USES THEREOF
The present invention is based on the discovery of genetic polymorphisms that are associated with cardiovascular disorders, particularly acute coronary events such as myocardial infarction and... |
|
|
US20110002907 |
Methods, Systems, Compositions And Dosage Forms For Diagnosing And Treating Male Infertility
Methods and systems are provided for diagnosing male infertility relating to inadequate production of phosphatidic acid and are complementary to the routine tests, assessing sperm count, motility,... |
|
|
US20100310508 |
METHODS OF TREATMENT INVOLVING p21/CIP1
The onset ratios and pathological conditions of collagen-induced arthritis and adjuvant arthritis in model mice and rats, respectively, were successfully ameliorated by topically expressing the... |
|
|
US20130338165 |
Use of Compounds Elevating Glutathione Levels for the Treatment of Parkinson's Disease
Methods of treating Parkinson's Disease comprising administering compounds that up-regulate cystine-glutamate exchange (system Xc−) and/or increase glutathione levels in the brain cells. Preferred... |
|
|
US20140323413 |
METHODS OF DIAGNOSING AND TREATING VASCULAR ASSOCIATED MACULOPATHY AND SYMPTOMS THEREOF
Disclosed herein are methods and compositions for the diagnosis and treatment of Vascular Associated Maculopathy, or a symptom thereof, in a subject. Disclosed herein are methods and compositions... |
|
|
US20130072561 |
METHODS FOR THE TREATMENT AND PREVENTION OF AGE-RELATED RETINAL DYSFUNCTION
A method of treating or preventing age-related retinal dysfunction involves administering to a patient a pharmaceutically effective amount of a synthetic retinal derivative repeatedly over a... |
|
|
US20120107401 |
OSTEOCONDUCTIVE MATRICES COMPRISING STATINS AND METHODS OF USING THE SAME
Osteoconductive matrices and methods are provided that have one or more statins disposed therein. The matrices may be injected into a fracture site. The osteoconductive matrices provided allow for... |
|
|
US20140199378 |
NEW NATURAL AND SYNTHETIC COMPOUNDS FOR TREATING CANCER AND OTHER DISEASES
This invention provides a method of synthesizing new active compounds for pharmaceutical uses including cancer treatment, wherein the cancers comprise breast, leukocytic, liver, ovarian, bladder,... |
|
|
US20110159017 |
TRYTOPHAN CATABOLISM IN CANCER TREATMENT AND DIAGNOSIS
The unexpected expression of tryptophan 2,3-dioxygenase (TDO2) in cancer cells and tumors has been established. Methods for diagnosing cancer based on the expression of TDO2 are provided, as are... |
|
|
US20110064712 |
Dietary Supplement Compositions and Methods of Making and Using the Same
Dietary supplement compositions are disclosed. Methods of making and using dietary supplement compositions are also disclosed. |
|
|
US20140072550 |
GENETIC POLYMORPHISMS ASSOCIATED WITH CORONARY EVENTS AND DRUG RESPONSE, METHODS OF DETECTION AND USES THEREOF
The present invention provides compositions and methods based on genetic polymorphisms that are associated with coronary heart disease (particularly myocardial infarction), aneurysm/dissection,... |
|
|
US20140235605 |
GENETIC POLYMORPHISMS ASSOCIATED WITH STATIN RESPONSE AND CARDIOVASCULAR DISEASES, METHODS OF DETECTION AND USES THEREOF
The present invention provides compositions and methods based on genetic polymorphisms that are associated with response to statin treatment, particularly for reducing the risk of cardiovascular... |
|
|
US20110269735 |
GENETIC POLYMORPHISMS ASSOCIATED WITH STATIN RESPONSE AND CARDIOVASCULAR DISEASES, METHODS OF DETECTION AND USES THEREOF
The present invention provides compositions and methods based on genetic polymorphisms that are associated with response to statin treatment, particularly for reducing the risk of cardiovascular... |
|
|
US20130030051 |
GENETIC POLYMORPHISMS ASSOCIATED WITH CARDIOVASCULAR DISEASES, METHODS OF DETECTION AND USES THEREOF
The present invention provides compositions and methods based on genetic polymorphisms that are associated with cardiovascular diseases, particularly coronary heart disease (especially myocardial... |
|
|
US20130005718 |
COMPOSITIONS AND METHODS OF TREATING CHRONIC PAIN BY ADMINISTERING PROPOFOL DERIVATIVES
Compositions and methods for managing or treating chronic pain are provided. More particularly, methods are provided for managing or treating chronic pain by administering to a patient in need... |
|
|
US20120107383 |
OSTEOCONDUCTIVE MATRICES COMPRISING CALCIUM PHOSPHATE PARTICLES AND STATINS AND METHODS OF USING THE SAME
Osteoconductive matrices and methods are provided that have one or more statins disposed in calcium phosphate particles. The matrices may be injected into a fracture site. The osteoconductive... |
|
|
US20130217685 |
COMPOUNDS FOR MODULATING RNA BINDING PROTEINS AND USES THEREFOR
The invention relates to compositions and methods for inhibiting RNA binding proteins (e.g., MEX-3, MEX-5 and POS-1), as well as methods for treating and preventing disorders associated with... |
|
|
US20110065704 |
COMPOUNDS FOR MODULATING RNA BINDING PROTEINS AND USES THEREFOR
The invention relates to compositions and methods for inhibiting RNA binding proteins (e.g., MEX-3, MEX-5 and POS-1), as well as methods for treating and preventing disorders associated with... |
|
|
US20110251155 |
Methods of Using Diacerein as an Adjunctive Therapy for Diabetes
The present invention provides methods of treating type II diabetes using combinations of diacerein or its derivatives with other antidiabetic agents. The methods may also allow improving glycemic... |
|
|
US20120003198 |
Lutein/Zeaxanthin for glare protection
The invention relates to the improvement of visual performance, particularly of visual performance in the darkness, by administration of a colorant that is capable of being incorporated into eye... |
|
|
US20130150432 |
EFFICACY OF CANCER THERAPY
Embodiments of the invention provide a method of improving the efficacy of an anti-cancer therapy and a method of treatment of cancer by normalizing angiogenesis in cancer. By enhancing the cell... |
|
|
US20110217301 |
METHODS FOR TREATING OR SCREENING FOR COMPOUNDS FOR THE TREATMENT OF SEPSIS
The present invention relates to a method for treating and screening for compounds for the treatment of sepsis. More specifically, the treatment and screening methods are based on the discovery... |
|
|
US20120277308 |
COMPOUNDS FOR TREATING CANCER AND OTHER DISEASES
This invention provides a method of synthesizing new active compounds for pharmaceutical uses including cancer treatment, wherein the cancers comprise breast, leukocytic, liver, ovarian, bladder,... |
|
|
US20110098314 |
STATINS FOR THE TREATMENT OF OCULAR HYPERTENSION AND GLAUCOMA
The use of HMG-CoA reductase inhibitors (e.g., statins) to treat glaucoma, control intraocular pressure, preserve the trabecular meshwork, protect against ocular neurodegeneration and/or protect... |
|
|
US20120283267 |
COMPOSITIONS AND METHODS FOR THE TREATMENT OF GIARDIASIS
Methods of treating exposure to Giardia lamblia and/or giardiasis and methods of antagonizing Giardia lamblia attachment to the intestinal wall of a subject are described herein. |
|
|
US20130085180 |
ORAL BIOAVAILABLE PENTAMIDIN PRODRUGS FOR TREATMENT OF DISEASES
The present invention relates to prodrug derivatives of pentamidine, their use in the treatment and/or prophylaxis of diseases such as tumor diseases, as well as leishmaniasis, trypanosomiasis,... |
|
|
US20110263545 |
HEPATOPROTECTANT ACETAMINOPHEN MUTUAL PRODRUGS
The present invention provides hepatoprotectant acetaminophen mutual prodrugs, which have an acetaminophen moiety covalently linked to a second moiety that may act as a hepatoprotectant against... |
|
|
US20130029922 |
FORMULATIONS FROM NATURAL PRODUCTS, TURMERIC, PACLITAXEL, AND ASPIRIN
The invention provides novel compounds and formulations of turmeric oil, fish oil, aspirin and anti-cancer drugs (paclitaxel) having anti-inflammatory, analgesic and/or anti-cancer activity. |
|
|
US20050215618 |
Treating vascular events with statins by inhibiting PAR-1 and PAR-4
The present invention relates to new methods for treating and/or preventing vascular events by inhibiting G-coupled Protease Activating Receptor (PAR)-1 and/or PAR-4 with the administration of... |
|
|
US20120040976 |
SMALL MOLECULE IMMUNOMODULATORS FOR ALZHEIMER'S DISEASE
Disclosed are methods for identifying individuals suffering from a CNS disorder (including Alzheimer's Disease, ALS, behavioral disorders, and the like) that could be treated with a CNS drug with... |
|
|
US20150111965 |
ORALLY BIOAVAILABLE PENTAMIDINE PRODRUGS FOR THE TREATMENT OF DISEASES
The present invention relates to prodrug derivatives of pentamidine, their use in the treatment and/or prophylaxis of diseases such as tumor diseases, as well as leishmaniasis, trypanosomiasis,... |
|
|
US20130115281 |
PHARMACEUTICAL FORMULATIONS OF STATINS AND OMEGA-3 FATTY ACIDS FOR ENCAPSULATION
A multi phase soft gelatin dosage form comprising at least one preformed solid dosage form comprising a statin compound and at least one liquid fill phase comprising Omega-3 fatty acids. The multi... |
|
|
US20050026992 |
Treatment and prevention of cardiovascular events
A pharmaceutical dosage form for treating or preventing cardiovascular events comprises therapeutic amounts of: a β-adrenergic receptor antagonist, a diuretic, or both; a cholesterol-lowering... |
|
|
US20150231045 |
ANTI-DANDRUFF COMPOSITION COMPRISING 1-ACETOXYCHAVICOL ACETATE
The present invention relates to an anti-dandruff composition comprising 1-acetoxychavicol acetate (I). Furthermore, the present invention relates to a method for preparing said anti-dandruff... |
|
|
US20110166226 |
PROCESS FOR OBTAINING AN EXTRACT RICH IN ROSMARINIC ACID (RA) FROM THE PLANT ORIGANUM VULGARE AND ITS USE FOR THE TREATMENT OF DIABETES
Diabetes consists of a worldwide public health concern that leads to high levels of morbidity and premature mortality and affects millions of people in countries of any level of development. It is... |
|
|
US20070093552 |
Early insulin secretion stimulator
The invention provides an early insulin secretion stimulator consisting of corosolic acid, etc. The early insulin secretion stimulator of the invention is capable of rapidly inducing secretion of... |
|
|
US20100330212 |
SKIN SENSITIZER DELIVERY SYSTEM
A skin-sensitizing formulation is provided in an edible, softgel pill. A person engaged in a sexual activity bites down on the pill, thereby effectuating the oral release of the skin-sensitizing... |
|
|
US20050222122 |
Statin therapy for enhancing cognitive maintenance
The present invention relates to a method of treating dementia or a memory disorder comprising administration of a therapeutically effective amount of galantamine (I) and a statin (II). The... |
|
|
US20050084478 |
Combination therapy using interferon-tau
Methods of treatment comprised of a combination treatment regimen of interferon-tau (IFNτ) and one or more additional agents are described. In the combined treatment method, IFNτ is orally... |
|
|
US20070099864 |
Use of o-atp for the treatment of diseases involving angiogenesis
The use of o-ATP as a pharmacological agent useful for the treatment of diseases in whose onset or progression angiogenesis is involved, such as ocular diseases, atherosclerotic processes or tumors. |
|
|
US20110046599 |
Multi-Day Delivery Of Biologically Active Substances
Compositions and methods for modifying biologically active substances to achieve multi-day delivery of such substances, particularly through oral or parenteral administration, are disclosed. The... |
|
|
US20140200254 |
D-SERINE TRANSPORTER INHIBITORS AS PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS
The present invention relates to pharmaceutical compositions comprising D-serine transporter inhibitors and therapeutic methods using such pharmaceutical compositions in methods for the treatment... |
|
|
US20110033474 |
INHIBITION OF PLATELET AGGREGATION
The present invention provides methods and compositions for preventing platelet aggregation and for treating individuals suffering from conditions or undergoing procedures that may result in... |
|
|
US20110319349 |
Methods for Reducing Platelet Activation and for the Treatment of Thrombotic Events
Methods and compositions for the treatment or prophylaxis of a disorder associated with platelet activation or enhanced thrombin activity are provided, that include the administration of an... |